BACKGROUND AND PURPOSE: Toward the goal of designing a clinical trial using imaging parameters to treat stroke patients with unknown onset time, we investigated the timing of changes on MRI in patients with well-defined stroke onset. METHODS: Hypothesis-generating (n=85) and confirmatory (n=111) samples were scored by blinded readers for fluid-attenuated inversion recovery (FLAIR) hyperintensity in diffusion-positive regions. Reader-measured signal intensity ratio (SIR) of the lesion to contralateral tissue was compared with SIR measured by coregistration. RESULTS: Lesion conspicuity increased with time on FLAIR (P=0.006). Qualitative assessment of FLAIR-negative vs FLAIR hyperintensity (k=0.7091; 95% CI, 0.61-0.81) showed good interrater agreement. Subtle hyperintensity was less reliably categorized (k=0.59; 95% CI, 0.47-0.71). Reader-measured SIR <1.15 can identify patients within the treatable time window of 4.5 hours (positive predictive value=0.90). The SIR was greater for right hemisphere lesions (P=0.04) for a given reported time from stroke symptom onset. CONCLUSIONS: The SIR on FLAIR provides a quantitative tool to identify early ischemic strokes. In developing SIR thresholds, right hemisphere lesions may confound the accurate estimate of stroke onset time. Image coregistration for thrombolytic trial enrollment is not necessary. A SIR <1.15 on FLAIR yields a practical estimate of stroke onset within 4.5 hours.
BACKGROUND AND PURPOSE: Toward the goal of designing a clinical trial using imaging parameters to treat strokepatients with unknown onset time, we investigated the timing of changes on MRI in patients with well-defined stroke onset. METHODS: Hypothesis-generating (n=85) and confirmatory (n=111) samples were scored by blinded readers for fluid-attenuated inversion recovery (FLAIR) hyperintensity in diffusion-positive regions. Reader-measured signal intensity ratio (SIR) of the lesion to contralateral tissue was compared with SIR measured by coregistration. RESULTS: Lesion conspicuity increased with time on FLAIR (P=0.006). Qualitative assessment of FLAIR-negative vs FLAIR hyperintensity (k=0.7091; 95% CI, 0.61-0.81) showed good interrater agreement. Subtle hyperintensity was less reliably categorized (k=0.59; 95% CI, 0.47-0.71). Reader-measured SIR <1.15 can identify patients within the treatable time window of 4.5 hours (positive predictive value=0.90). The SIR was greater for right hemisphere lesions (P=0.04) for a given reported time from stroke symptom onset. CONCLUSIONS: The SIR on FLAIR provides a quantitative tool to identify early ischemic strokes. In developing SIR thresholds, right hemisphere lesions may confound the accurate estimate of stroke onset time. Image coregistration for thrombolytic trial enrollment is not necessary. A SIR <1.15 on FLAIR yields a practical estimate of stroke onset within 4.5 hours.
Authors: R Sterzi; G Bottini; M G Celani; E Righetti; M Lamassa; S Ricci; G Vallar Journal: J Neurol Neurosurg Psychiatry Date: 1993-03 Impact factor: 10.154
Authors: J Fiebach; O Jansen; P Schellinger; M Knauth; M Hartmann; S Heiland; H Ryssel; O Pohlers; W Hacke; K Sartor Journal: Neuroradiology Date: 2001-08 Impact factor: 2.804
Authors: Harold P Adams; Mark B Effron; James Torner; Antoni Dávalos; Judith Frayne; Philip Teal; Jacques Leclerc; Barry Oemar; Lakshmi Padgett; Elliot S Barnathan; Werner Hacke Journal: Stroke Date: 2007-11-21 Impact factor: 7.914
Authors: Harold P Adams; Enrique C Leira; James C Torner; Elliot Barnathan; Lakshmi Padgett; Mark B Effron; Werner Hacke Journal: Stroke Date: 2008-09-04 Impact factor: 7.914
Authors: Martin Ebinger; Ivana Galinovic; Michal Rozanski; Peter Brunecker; Matthias Endres; Jochen B Fiebach Journal: Stroke Date: 2009-12-24 Impact factor: 7.914
Authors: Lee H Schwamm; Ona Wu; Shlee S Song; Lawrence L Latour; Andria L Ford; Amie W Hsia; Alona Muzikansky; Rebecca A Betensky; Albert J Yoo; Michael H Lev; Gregoire Boulouis; Arne Lauer; Pedro Cougo; William A Copen; Gordon J Harris; Steven Warach Journal: Ann Neurol Date: 2018-04-27 Impact factor: 10.422
Authors: Malik M Adil; Marie Luby; John K Lynch; Amie W Hsia; Chandni P Kalaria; Zurab Nadareishvili; Lawrence L Latour; Richard Leigh Journal: J Stroke Cerebrovasc Dis Date: 2020-07-04 Impact factor: 2.677
Authors: Bastian Cheng; Mathias Brinkmann; Nils D Forkert; Andras Treszl; Martin Ebinger; Martin Köhrmann; Ona Wu; Dong-Wha Kang; David S Liebeskind; Thomas Tourdias; Oliver C Singer; Soren Christensen; Marie Luby; Steven Warach; Jens Fiehler; Jochen B Fiebach; Christian Gerloff; Götz Thomalla Journal: J Cereb Blood Flow Metab Date: 2012-10-10 Impact factor: 6.200
Authors: Shanyan Chen; Jiankun Cui; Tao Jiang; Emilia S Olson; Quan-Yu Cai; Ming Yang; Wei Wu; James M Guthrie; J D Robertson; Stuart A Lipton; Lixin Ma; Roger Y Tsien; Zezong Gu Journal: J Cereb Blood Flow Metab Date: 2015-12-17 Impact factor: 6.200
Authors: Robert W Regenhardt; Martin Bretzner; Maria Clara Zanon Zotin; Anna K Bonkhoff; Mark R Etherton; Sungmin Hong; Alvin S Das; Naif M Alotaibi; Justin E Vranic; Adam A Dmytriw; Christopher J Stapleton; Aman B Patel; Gregory Kuchcinski; Natalia S Rost; Thabele M Leslie-Mazwi Journal: J Neuroimaging Date: 2021-09-10 Impact factor: 2.486
Authors: Vince I Madai; Ivana Galinovic; Ulrike Grittner; Olivier Zaro-Weber; Alice Schneider; Steve Z Martin; Federico C von Samson-Himmelstjerna; Katharina L Stengl; Matthias A Mutke; Walter Moeller-Hartmann; Martin Ebinger; Jochen B Fiebach; Jan Sobesky Journal: PLoS One Date: 2014-03-21 Impact factor: 3.240